The test will initially be available at about 50 American research institutes and hospitals that specialise in Alzheimer’s ...

Eisai has put direct-to-consumer (DTC) advertising at the heart of its ongoing efforts to expand demand for Leqembi. | Eisai ...

Analysts at BMO Capital Markets said in a weekend note that a non-invasive blood test could help boost uptake of Alzheimer’s ...

Google became the gateway to the internet by perfecting its search engine. For two decades, it surfaced 10 blue links that ...

The U.S. Food and Drug Administration has cleared Fujirebio Diagnostics' blood test to diagnose Alzheimer's disease, the ...

Sen. Susan Collins asked Secretary of State Marco Rubio about the Trump administration's cutbacks to global health initiatives during Rubio's appearance before a Senate committee Tuesday. "I am ...

A dementia-focused transatlantic venture capital initiative has secured $269 million in commitments for its second fund. | A ...

BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today announced that Leqembi sales are expected to total JPY 76.5 billion (approximately SEK 5.1 billion) for their fiscal year (FY) 2025 ...

U.S. health officials have endorsed the first blood test that can help diagnose Alzheimer’s. The test would help identify ...

Experts say the test could dramatically improve access to earlier, more accurate diagnoses, particularly for older Americans ...

The Food and Drug Administration has cleared Fujirebio Diagnostics’ blood test to diagnose Alzheimer’s disease, the regulator ...

Hi, it’s Amber in Hong Kong. Across the strait in Taiwan, breakthrough Alzheimer’s drugs are finally becoming available but ...